DXB ASX News

19 November 2024

Successful planned IDMC review of ACTION3 trial

Dimerix receives IDMC approval to continue ACTION3 kidney trial unchanged.

Dimerix Clinical Trials FSGS Biopharmaceutical Stock Market News

Posted on: 19/11/2024

Read More

14 November 2024

Dimerix Receives $7.9M R&D Tax Incentive Rebate

Dimerix enhances cash position with a $7.9 million R&D tax rebate.

Dimerix R&D Tax Incentive Biopharmaceutical Clinical Trials Stock Market News

Posted on: 14/11/2024

Read More

23 July 2024

Quarterly Appendix 4C and Activities Report

Dimerix reports significant progress in DMX-200 licensing and clinical trials.

Dimerix Biopharmaceuticals Clinical Trials Stock Market News DMX-200

Posted on: 23/07/2024

Read More